New medication for postpartum depression

What to know about the first drug for postpartum depression? What is the best postpartum depression treatment? Do I have a form of postpartum depression?

This approval marks the first time a drug has been specifically approved to treat postpartum depression , providing an important new treatment option, said Tiffany Farchione, M. The medication , called brexanolone, is the first drug specifically approved for postpartum depression. To take the medicine, women must be supervised by a medical professional who gives the medicine intravenously, or through your veins.

SAGE-54 now called brexanolone, is an allosteric modulator of GABAA receptors. Will a promising new drug, Zulresso. Samantha Meltzer-Brody. The drug was very effective for treating women quickly with severe postpartum depression , Meltzer-Brody said. Ask your doctor or therapist about local support groups for new moms or women who have postpartum depression.

Kristina Deligiannidis, a. Most of the time, it occurs sometime in the first weeks after delivery. Monique Dorman is handling mom-life well, but when her son had just been born, the Seminole County nurse said she was.

Read about postpartum depression symptoms, treatment, and causes. Postpartum depression (PPD) affects one out of every eight women in the U. Statistics indicate that PPD can affect as many as of new fathers, as well. Untreated postpartum depression can last for months or longer, sometimes becoming a chronic depressive disorder. It requires treatment, and the good news is that good treatment is available. The specific treatment you.

Many new moms deal with a wide range of emotions after having a baby. You’ve done the right thing to seek help. There are a variety of ways to treat postpartum depression. This is great news for women experiencing moderate-to-severe PPD as it offers a new therapeutic option.

Food and Drug Administration (FDA) recently approved the FIRST-EVER drug (brexanolone, brand name ZULPRESSO) specifically indicated to treat postpartum depression (PPD). A new treatment could offer much-needed help to some new mothers with this. A new drug being studied could one day be an important treatment option for women suffering postpartum depression (PPD), a condition that affects about percent of women after giving birth.

Up until this point, new mothers experiencing postpartum depression have been prescribed the same antidepressants used for treating depression in the general population, such as selective. The new medication is administered through a continuous intravenous. When in reality, someone struggling with Postpartum Depression likely does not feel that way. However, the University of Iowa Hospitals and Clinics, along with other health-care facilities, will need to be certified in the FDA Risk Evaluation and Mitigation Strategies Program in order to offer it to their patients.

But for one in nine new mothers, that joy can be rapidly diminished by the crippling menace of postpartum depression (PPD).

Zulresso (brexanolone), a new medication from Sage Therapeutics, may help. The first FDA-approved drug for postpartum depression is here. But how exactly does the drug work, and what makes it different from other medications for depression ? One of the biggest risk factors for paternal postpartum depression is the development of postpartum depression in the mother.

Half of all men who have a spouse suffering from postpartum depression will be depressed as well. Men often have a difficult time discussing their postpartum depression symptoms.